Search results
Results from the WOW.Com Content Network
Impetigo is more likely to infect children ages 2–5, especially those that attend school or day care. [ 3 ] [ 15 ] [ 1 ] 70% of cases are the nonbullous form and 30% are the bullous form. [ 3 ] Impetigo occurs more frequently among people who live in warm climates.
Dukes' disease, named after Clement Dukes (1845–1925), [1] [2] also known as fourth disease, [3] Filatov-Dukes' disease (after Nil Filatov), [4] Staphylococcal Scalded Skin Syndrome (SSSS), [5] or Ritter's disease [6] is an exanthem (rash-causing) illness primarily affecting children and historically described as a distinct bacterial infection, though its existence as a separate disease ...
This infection-related cutaneous condition article is a stub. You can help Wikipedia by expanding it.
Ringworm will last between two and four weeks with treatment. [7] Tinea infections can be combatted orally or topically with numerous different medications. Some topical treatments include Mentax 1%, Lamisil 1%, Naftin 1% and Spectazole and these creams should be applied two times a day until the infection is gone.
Pressure ulcers can trigger other ailments, cause considerable suffering, and can be expensive to treat. Some complications include autonomic dysreflexia, bladder distension, bone infection, pyarthrosis, sepsis, amyloidosis, anemia, urethral fistula, gangrene and very rarely malignant transformation (Marjolin's ulcer – secondary carcinomas in chronic wounds).
The infections caused by a HSV Type 1 virus may be primary or recurrent. [8] Studies show that even though most of the individuals who are exposed to the virus get infected, only 10% from them will develop sores as well. These types of sores appear within two to twenty days after exposure and usually do not last longer than ten days.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
In 2009, acyclovir in combination with hydrocortisone cream, marketed as Xerese, was approved in the United States for the early treatment of recurrent herpes labialis (cold sores) to reduce the likelihood of ulcerative cold sores and to shorten the lesion healing time in adults and children (six years of age and older). [61] [62]